4 completed. 2 Phase 1, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Rabipur®: new trials by email Literature Review of Rabipur® trials Research Report on Rabipur®
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Assess the Safety, Reactogenicity and Immune Response of CureVac's Candidate Rabies mRNA Vaccine in Healthy Adults Rabipur®, Rabies mRNA vaccine CV7202 - Rabies | Phase 1 | Completed | CureVac | 53 | 2018-10-12 | 2024-12-19 |
| Seasonal Malaria Vaccination (RTS,S/AS01) and Seasonal Malaria Chemoprevention (SP/AQ) RABIPUR®, RTS,S/AS01, SMC with SP+AQ - Malaria,Falciparum, Children, Only | Phase 3 | Completed | London School of Hygiene and Tropical Medicine | 5920 | 2017-04-17 | 2022-04-07 |
| Efficacy and Safety of a PIKA Rabies Vaccine Containing the PIKA Adjuvant With an Accelerated Regimen RABIPUR®, PIKA rabies vaccine - Rabies | Phase 2 | Completed | Yisheng Biopharma (Singapore) Pte. Ltd. | 126 | 2016-02-01 | 2016-11-08 |
| Safety and Efficacy of a PIKA Rabies Vaccine Containing the PIKA Adjuvant RABIPUR®, PIKA rabies vaccine, PIKA rabies vaccine with an accelerated regimen - Rabies | Phase 1 | Completed | Yisheng Biopharma (Singapore) Pte. Ltd. | 37 | 2015-02-01 | 2016-01-15 |
Rabies (3) · Malaria (1) · Malaria, Falciparum (1)
Yisheng Biopharma (Singapore) Pte. Ltd. (2) · CureVac (1) · London School of Hygiene and Tropical Medicine (1)
Singapore (2) · Belgium (1) · Burkina Faso (1) · Germany (1) · Mali (1)
Limin Wijaya (2) · Alassane Dicko, Professor (1) · Jean Bosco Ouedraogo, Professor (1)
PMID 37821317, PMID 28118938, PMID 29174316, PMID 32933955, PMID 33487468, PMID 34432975, PMID 34894221, PMID 35193608, PMID 36203149, PMID 39915506
2017 (1)